Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Cyclacel Pharmaceuticals, Inc..
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Cyclacel Pharmaceuticals, Inc. Identifier:
First received: December 23, 2007
Last updated: November 7, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):